Intended for healthcare professionals


Combination treatment for hepatitis C is not being given

BMJ 2000; 321 doi: (Published 07 October 2000) Cite this as: BMJ 2000;321:899
  1. G R Foster (, consultant hepatologist,
  2. R Chapman, consultant gastroenterologist
  1. Liver Centre, Imperial College School of Medicine at St Mary's, St Mary's Hospital, London W2 1PG
  2. Department of Gastroenterology, John Radcliffe Infirmary, Oxford OX3 9DU On behalf of C Change

    EDITOR—Current estimates suggest that up to 0.7% (400 000 individuals) of the population of the United Kingdom are infected with the hepatitis C virus.1 In some (roughly 30%) of these people the virus causes a progressive hepatitis that leads to cirrhosis and cancer.2 European guidelines recommend that patients with progressive hepatitis C are treated with interferon and ribavirin.3 This cures 40%4 and leads to an improvement in …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription